| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 05/23/2001 | CN1066142C 喹唑啉衍生物 Quinazoline derivatives |
| 05/23/2001 | CN1066039C High lathering anti-dandruft shampoo having improved deposition of particulate anti-dandruff agent |
| 05/22/2001 | US6235787 Antiinflammatory agents; rheumatic diseases; bone disorders; skin disorders; multiple sclerosis |
| 05/22/2001 | US6235778 Anticoagulants |
| 05/22/2001 | US6235296 Comprising:a non-aqueous solvent component(di-n-butyl adipate, di-isopropyl adipate) a anionic, amphoteric,or nonionic surfactants, a thickener and one abrasive |
| 05/22/2001 | US6233841 Dehydration plant |
| 05/17/2001 | WO2001034593A1 Compound with growth hormone releasing properties |
| 05/17/2001 | WO2001034551A1 Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders |
| 05/17/2001 | WO2001034189A2 Vaccines for mycoplasma bovis and methods of use |
| 05/17/2001 | WO2001034139A1 Pharmaceutical formulation containing tolterodine and its use |
| 05/17/2001 | WO2001003648A3 Oregano-based therapeutic composition |
| 05/17/2001 | WO2000030671A9 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto |
| 05/17/2001 | CA2390613A1 Vaccines for mycoplasma bovis and methods of use |
| 05/16/2001 | EP1098897A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 05/16/2001 | EP1098662A2 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
| 05/16/2001 | EP1098660A1 Encapsulation of water soluble peptides |
| 05/16/2001 | EP1098657A1 Composition for treating obesity and aesthetic treatment method |
| 05/16/2001 | EP1098639A1 Use of a glucose uptake enhancer for reducing apoptosis |
| 05/16/2001 | EP1011673B1 Novel niddm regimen |
| 05/16/2001 | CN1295560A C11 oxymyl and hydroxylamino prostaglandins useful as medicaments |
| 05/16/2001 | CN1065768C Methods of treatment of motor neuron cliseases using members of BDNF/NT-3/NGF family of molecule |
| 05/15/2001 | US6232349 And polycarbonates, polyesters or polyamides water-soluble, with a rigid backbone and predictable anion spacing |
| 05/15/2001 | US6231887 Drugs of pyranone derivatives |
| 05/15/2001 | US6231870 Oral administration of pneumoccal antigens |
| 05/15/2001 | US6231565 Robotic arm DLUs for performing surgical tasks |
| 05/10/2001 | WO2001032190A1 Antiviral composition comprising an extraction product of fava b eans |
| 05/09/2001 | EP1097937A1 N-acyl derivatives of the LL-E33288 antitumor antibiotics |
| 05/09/2001 | EP1097719A1 NEP inhibitors for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097718A1 NPY antagonists for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097710A2 Combination product for treating niddm |
| 05/09/2001 | EP1097707A1 Treatment of female sexual dysfunction |
| 05/09/2001 | EP1097706A1 Phosphodiesterase inhibitors for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097200A1 Pharmaceutical uses of nab1 and nab2 |
| 05/09/2001 | EP1097139A1 Quinoline derivatives |
| 05/09/2001 | EP1096944A1 Extracts of zanthoxylum bungeanum, pharmaceutical and cosmetic formulations containing them |
| 05/09/2001 | EP1096917A1 Methods of exfoliation using n-acetyl glucosamine |
| 05/09/2001 | CN1065432C Antilipemic monascus for decreasing fat and its prepn. method |
| 05/08/2001 | CA2324484A1 Compounds for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2323464A1 Compounds for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2323191A1 Compounds for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2323183A1 Compounds for the treatment of female sexual dysfunction |
| 05/03/2001 | WO2001030759A2 Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 05/03/2001 | WO2000074695A3 Tanacetum parthenium extract |
| 05/03/2001 | WO2000066164A8 Contraceptive compositions containing antiprogestinic and progestinic |
| 05/03/2001 | CA2389020A1 Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 05/03/2001 | CA2388611A1 Transdermal drug delivery devices |
| 05/03/2001 | CA2387229A1 Biodegradable microparticles with novel erythropoietin stimulating protein |
| 05/02/2001 | EP1095140A2 Neurotrophic factors |
| 05/02/2001 | EP1094835A1 Pharmaceutical composition comprising human apotransferrin and process for manufacturing of the composition |
| 05/02/2001 | EP1094818A1 Use of tricyclic antidepressants for local analgesia |
| 05/02/2001 | EP1094808A1 Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone |
| 05/02/2001 | CN1293569A New treatments for nervous disorders |
| 05/02/2001 | CN1065127C Hair styling shampoos |
| 05/01/2001 | US6225355 Process for removing bile salts from a patient and alkylated compositions therefor |
| 05/01/2001 | US6225342 Use of calendula glycosides for the treatment of psoriasis |
| 05/01/2001 | US6224885 Barrier cream comprising hexamethylenetetramine or derivative thereof |
| 05/01/2001 | US6224875 Tanacetum parthenium extract and method of obtaining same |
| 05/01/2001 | US6224662 Use of novel glass compositions in preparing dental glass pillars and support pillars, and method for producing the glass pillars |
| 05/01/2001 | CA2042487C Hair colorants |
| 04/26/2001 | WO2001029026A1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 04/26/2001 | WO2001028992A2 New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 04/26/2001 | WO2001028978A1 Bicyclic amino acids as pharmaceutical agents |
| 04/26/2001 | CA2387855A1 Melanoma vaccine and methods of making and using same |
| 04/26/2001 | CA2386910A1 New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 04/25/2001 | EP1093379A2 Use of inhibitors of protein kinase c epsilon to treat pain |
| 04/25/2001 | EP0994872B1 4-phenylpiperidine compounds |
| 04/25/2001 | CN1292779A Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors |
| 04/25/2001 | CN1292702A Newcontraceptive kit for monotherapy |
| 04/25/2001 | CN1292697A Anti-viral compound |
| 04/25/2001 | CN1292683A Compositions containing organic compounds |
| 04/25/2001 | CN1292379A Preparation method of pyrazolzo [4,3-d] pyrimidine-7-ketone-3-pyridyl sulfonyl compound and its intermediate |
| 04/25/2001 | CN1292279A Medicine for curing emmeniopathy and its preparation method |
| 04/24/2001 | US6222038 As substance p antagonists; in therapy of gastrointestinal disorders, inflammatory disorders, central nervous system disorders and pain |
| 04/24/2001 | US6221394 In one portion thereof, substantially single (+)-tramadol, and, in another separate portion thereof, substantially single (-)-tramadol; the different tramadol enantiomers are released at different rates from the dosage form. |
| 04/24/2001 | US6221389 At least one organic phospholipid capable of forming bilayers in aqueous solution;at least one amphoteric surfactant; and at least one nonionic surfactant present in an amount by weight equal to or greater than the amount of the phospholipid. |
| 04/24/2001 | US6221356 Method of preparation of biologically active Ginkgo biloba product |
| 04/19/2001 | WO2001027113A2 PYRAZOLO `4,3-d! PYRIMIDINE DERIVATIVES |
| 04/19/2001 | WO2001027112A1 5-(2-substituted-5-heterocyclylsulphonylpyrid-3-yl)-dihydropyrazolo[4,3-d]pyrimidin-7-ones as phosphodiesterase inhibitors |
| 04/19/2001 | WO2001026666A2 Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba |
| 04/19/2001 | CA2387353A1 Pharmaceutically active compounds |
| 04/18/2001 | EP1092774A2 Borrelia burgdorferi antigen OspA, gene encoding it and uses thereof |
| 04/18/2001 | EP1092720A2 Process for the preparation of pyrazolo [4,3-d] pyrimidin-7-ones-3-pyridylsulphonyl compounds and intermediates thereof |
| 04/18/2001 | EP1091933A1 SUBSTITUTED $g(b)-DIKETONES AND THEIR USE |
| 04/18/2001 | EP1091753A1 Antiproliferative and antiviral proteins and peptides |
| 04/18/2001 | EP1091748A2 A pharmaceutical formulation useful for the treatment of hepatitis b, hepatitis c and other viral infections of the liver and a process for its preparation |
| 04/18/2001 | EP0663832B1 Use of 4'-iodo-4'-deoxydoxorubicin for the treatment of amyloidosis |
| 04/18/2001 | EP0576519B1 Improvements in or relating to contrast agents |
| 04/18/2001 | CN1292029A Compounds for therapy and diagnosis for lung cancer and method for their use |
| 04/18/2001 | CN1291894A Compositions comprising D-chiro-inositol for treating metabolic diseases characterized by hyperinsulinemia, hyperandrogenism, hyperlipidemia and/or anovulation |
| 04/18/2001 | CN1064710C Therapeutic uses of keratinocyte growth factor |
| 04/18/2001 | CN1064680C Process for preparing magnesium omeprazole |
| 04/17/2001 | US6218374 Pharmaceutical formulation |
| 04/17/2001 | CA2052323C Oligosaccharide conjugate vaccines |
| 04/12/2001 | WO2001025242A1 Novel thiazolo(4,5-d)pyrimidine compounds |
| 04/12/2001 | WO2001025200A1 Cyclic amine compounds as ccr5 antagonists |
| 04/12/2001 | WO2000076958A3 Mono- and disubstituted 3-propyl gamma-aminobutyric acids |
| 04/12/2001 | WO1998025575A3 Improved hydrogel composition |
| 04/12/2001 | CA2608807A1 Cyclic amine compounds as ccr5 antagonists |
| 04/11/2001 | EP1090027A1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same |
| 04/11/2001 | EP1090022A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |